Acute electrophysiologic effects of pirmenol in normal subjects and in patients with Wolff-Parkinson-White syndrome
- 1 April 1986
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 57 (10) , 775-781
- https://doi.org/10.1016/0002-9149(86)90612-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Pirmenol for control of ventricular arrhythmias: Oral dose-ranging and short-term maintenance studyThe American Journal of Cardiology, 1984
- Pharmacokinetics and Efficacy of Pirmenol Hydrochloride in the Treatment of Ventricular DysrhythmiaJournal of Cardiovascular Pharmacology, 1983
- Efficacy of Intravenous Pirmenol Hydrochloride for Treatment of Ventricular ArrhythmiasJournal of Cardiovascular Pharmacology, 1983
- Pirmenol kinetics and effective oral doseClinical Pharmacology & Therapeutics, 1982
- Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics.Circulation, 1982
- Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.Circulation, 1982
- Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1982
- Pirmenol Hydrochloride (CI-845)Journal of Cardiovascular Pharmacology, 1980
- Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibersEuropean Journal of Pharmacology, 1980
- Significance of the Sinus-Node Recovery TimeCirculation, 1972